Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ROIV✓SelectedUSD · ROIVMRNA vs ROIV performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs ROIV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
ROIV return
+380.2%
Excess return
-411.2%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioROIVExcessAlpha
1D-2.2%-0.8%-1.4%-2.0%
7D-12.7%-2.2%-10.5%-12.2%
30D-20.7%+5.0%-25.7%-21.5%
3M+46.3%+4.9%+41.3%+43.4%
6M+305.2%+19.3%+286.0%+285.8%
YTD+561.2%+78.1%+483.1%+470.9%
1Y+772.1%+90.7%+681.4%+641.1%
3Y+147.0%+339.3%-192.3%+78.1%
All-31.0%+380.2%-411.2%-57.8%

Cumulative growth

Daily Returns

Daily percentage return beside ROIV.

Daily Out/Under-Performance

Portfolio return minus ROIV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ROIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded ROIV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling